Mylan Inc. has signed a definitive agreement to acquire Agila Specialties Private Ltd., a developer, manufacturer and marketer of high-quality generic injectable products, from Strides Arcolab. The $1.6 billion cash acquisition expands Mylan’s global injectables platform and provides entry into new high-growth geographic markets. The transaction, subject to certain closing conditions, is expected to close in 4Q13.   Agila, headquartered in Bangalore, India, has a product portfolio of more ...